Omniome was acquired by Pacific Biosciences on September 20, 2021. Forge no longer actively tracks this company.
Omniome Funding Rounds and IPO Valuation
Date
Funding Round
Funding Raised
Price per Share
IPO Valuation
1/9/2020
Series C
$511MM
$XXX.XX
$XXX.XX
7/30/2018
Series B-1 and B-2
$233.69MM
$XXX.XX
$XXX.XX
1/1/2016
Series A-1 and A-2
$75.5MM
$XXX.XX
$XXX.XX
Based on primary financings
Learn more about Omniome
What is Omniome funding to date?
Omniome has raised $153.29MM with the following series: $75.5MM for Series A-1 and A-2, $233.69MM for Series B-1 and B-2, $511MM for Series C, $75.5MM for Series A-1 and A-2, $233.69MM for Series B-1 and B-2, $511MM for Series C.